Published date: 14 May 2021

Withdrawn opportunity - This means that the contract has been withdrawn early. This could be due to a change of circumstances.


Closing: 10 August 2020, 12am

Contract summary

Industry

  • Pharmaceutical products - 33600000

Location of contract

United Kingdom

Value of contract

£96,000,000

Procurement reference

CF-0048300D0O000000rwimUAA2

Published date

14 May 2021

Closing date

10 August 2020

Closing time

12am

Contract start date

6 November 2020

Contract end date

29 January 2021

Contract type

Supply contract

Procedure type

Open procedure (above threshold)

Any interested supplier may submit a tender in response to an opportunity notice.

This procedure can be used for procurements above the relevant contract value threshold.

This is an accelerated procedure.

Justification

The Covid-19 outbreak gave rise to an urgent need for DHSC to create a stockpile of medicines suitable for use in the Intensive Treatment Unit and End of Life facilities in order to be in a position to treat the population as required in case the Covid-19 outbreak escalates suddenly. This did not give DHSC sufficient time to comply with the standard open procedure time scales for this procurement. DHSC considers this to be a state of urgency which it has duly substantiated. Accordingly, DHSC has used the accelerated time limits permitted under the Public Contract Regulations 2015 (Regulation 27(5) for the open procedure) in respect of this procurement.

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

No

Description

A procurement exercise for supportive medicines that includes End of Life, Intensive Treatment Unit and Antibiotics medicines

More information

Previous notice about this procurement

Supportive Medicines including ITU, EOL & Antibiotics

  • Awarded contract
  • Published 25 November 2020

Links

About the buyer

Contact name

Health Family eCommercial System

Address

test
test
cf62 4qj
GB

Email

notifications@atamis.co.uk